110 related articles for article (PubMed ID: 10413213)
41. CD69 to CD3 ratio of peripheral blood mononuclear cells as a marker to monitor systemic lupus erythematosus disease activity.
Su CC; Shau WY; Wang CR; Chuang CY; Chen CY
Lupus; 1997; 6(5):449-54. PubMed ID: 9229364
[TBL] [Abstract][Full Text] [Related]
42. Successful treatment of systemic lupus erythematosus cerebritis with intravenous immunoglobulin.
Sherer Y; Levy Y; Langevitz P; Lorber M; Fabrizzi F; Shoenfeld Y
Clin Rheumatol; 1999; 18(2):170-3. PubMed ID: 10357127
[TBL] [Abstract][Full Text] [Related]
43. Coexistence of bullous pemphigoid and systemic lupus erythematosus.
Kumar V; Binder WL; Schotland E; Beutner EH; Chorzelski TP
Arch Dermatol; 1978 Aug; 114(8):1187-90. PubMed ID: 354534
[TBL] [Abstract][Full Text] [Related]
44. An unusual presentation of anti-Jo-1 syndrome, mimicking lung metastases, with massive pleural and pericardial effusions.
Mogulkoc N; Kabasakal Y; Ekren PK; Bishop PW
J Clin Rheumatol; 2006 Apr; 12(2):90-2. PubMed ID: 16601544
[TBL] [Abstract][Full Text] [Related]
45. A serological switching from anti-dsDNA to anti-Sm antibodies coincided with severe clinical manifestations of systemic lupus erythematosus (hemophagocytosis, profundus and psychosis).
Ishii M; Muramoto Y; Kosaka H; Ohshima S; Mima T; Katada Y; Hirohata S; Saeki Y
Lupus; 2007; 16(1):67-9. PubMed ID: 17283590
[No Abstract] [Full Text] [Related]
46. Systemic lupus erythematosus presenting as pleural effusion: report of a case.
Wang DY; Chang DB; Kuo SH; Yang S; Shiah DC; Chou HT; Luh KT
J Formos Med Assoc; 1995 Dec; 94(12):746-9. PubMed ID: 8541737
[TBL] [Abstract][Full Text] [Related]
47. Successful treatment of massive ascites due to lupus peritonitis with hydroxychloroquine in old- onset lupus erythematosus.
Hammami S; Bdioui F; Ouaz A; Loghmari H; Mahjoub S; Saffar H
Pan Afr Med J; 2014; 18():165. PubMed ID: 25422683
[TBL] [Abstract][Full Text] [Related]
48. Immunological studies in systemic lupus erythematosus.
Jin OC; Jacob E; Chua D; Lan YS; Hsii FP
J Med Assoc Thai; 1978 Jan; 61 Suppl 1():10-7. PubMed ID: 304878
[No Abstract] [Full Text] [Related]
49. Correlation between clinical activity and serological markers in a wide cohort of patients with systemic lupus erythematosus: an eight-year prospective study.
Villegas-Zambrano N; Martínez-Taboada VM; Bolívar A; San Martín M; Alvarez L; Marín MJ; López-Hoyos M
Ann N Y Acad Sci; 2009 Sep; 1173():60-6. PubMed ID: 19758133
[TBL] [Abstract][Full Text] [Related]
50. Massive bilateral pleural effusion as the only first presentation of systemic lupus erythematosus.
Bouros D; Panagou P; Papandreou L; Kottakis I; Tegos C
Respiration; 1992; 59(3):173-5. PubMed ID: 1439230
[TBL] [Abstract][Full Text] [Related]
51. Massive pleural effusion in systemic lupus erythematosus: thoracoscopic and immunohistological findings.
Mathlouthi A; Ben M'rad S; Merai S; Kovitz KL; Slabbynck H; Djenayah F
Monaldi Arch Chest Dis; 1998 Feb; 53(1):34-6. PubMed ID: 9632905
[TBL] [Abstract][Full Text] [Related]
52. Salmonella enterica Subspecies arizonae Detected from Bilateral Pleural Fluid in a Patient with Systemic Lupus Erythematosus and Malignant Lymphoma.
Shima N; Nakamura J; Saito K; Kamata Y; Nagatani K; Nagashima T; Iwamoto M; Akine D; Saito T; Sato K; Minota S
Intern Med; 2020 May; 59(9):1223-1226. PubMed ID: 32051382
[TBL] [Abstract][Full Text] [Related]
53. [A case of breast cancer with pleural metastasis responding to administration of intrapleural adriamycin and systemic chemotherapy with FEMP].
Ogasahara K; Takeda R; Nishizawa F; Yoshimura T; Denno R; Adachi Y; Takahashi J; Kohno Y; Bada K; Ohbayashi M
Gan To Kagaku Ryoho; 1987 Nov; 14(11):3140-2. PubMed ID: 3118815
[TBL] [Abstract][Full Text] [Related]
54. Relationship between anti-DNA antibodies complement consumption and circulating immune complexes in systemic lupus erythematosus.
Davis P; Cumming RH; Verrier-Jones J
Clin Exp Immunol; 1977 May; 28(2):226-32. PubMed ID: 301447
[TBL] [Abstract][Full Text] [Related]
55. A comparison of three anti-double stranded DNA antibody assays on sera from SLE and other diseases.
Clarke MC; Carr R; Burdash NM; Chen ZY; Ainsworth SK
Diagn Immunol; 1986; 4(6):288-93. PubMed ID: 3545632
[TBL] [Abstract][Full Text] [Related]
56. A case of toxic epidermal necrolysis-like skin lesions with systemic lupus erythematosus and review of the literature.
Yildirim Cetin G; Sayar H; Ozkan F; Kurtulus S; Kesici F; Sayarlioglu M
Lupus; 2013 Jul; 22(8):839-46. PubMed ID: 23761100
[TBL] [Abstract][Full Text] [Related]
57. [Case of bilateral chylothorax with systemic lupus erythematosus complicated by steroid-/immunosuppressant-resistant pleural effusion].
Narita Y; Naoki K; Hida N; Okamoto H; Kunikane H; Omori T; Kase M; Watanabe K
Nihon Kokyuki Gakkai Zasshi; 2008 Feb; 46(2):120-5. PubMed ID: 18318255
[TBL] [Abstract][Full Text] [Related]
58. [A patient with recurrent sigmoid colon cancer in whom pleural effusion and ascites resolved after FOLFOX 4 therapy].
Akamatsu M; Tsuji Y; Nakata W; Ohmae T; Ohata K; Matsubara S; Katamoto T
Gan To Kagaku Ryoho; 2007 Dec; 34(13):2305-7. PubMed ID: 18079636
[TBL] [Abstract][Full Text] [Related]
59. Characteristics of pleural effusions in systemic lupus erythematosus: differential diagnosis of lupus pleuritis.
Choi BY; Yoon MJ; Shin K; Lee YJ; Song YW
Lupus; 2015 Mar; 24(3):321-6. PubMed ID: 25318967
[TBL] [Abstract][Full Text] [Related]
60. [Levels of complement components in sera and pleural fluid in patients with various types of pleural pathology].
Cicioğlu R; Enacar N; Karabiyikoğlu G; Numanoğlu N
Mikrobiyol Bul; 1987 Jul; 21(3):185-93. PubMed ID: 3141750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
